Stimulating natural immunity to treat cancer

Biomune, Inc. is a privately-held corporation with exclusive patents on compounds that we developed. Our compounds have been shown to be effective in laboratory studies:

  • 100% remission of melanoma, lymphoma, and fibrosarcoma cancer in 98% of laboratory animals.

We are excited about these results! Our plan is to:

  • Conduct more studies in larger groups of laboratory animals;
  • Expand our research to include other forms of cancer;
  • Extend our work to clinical trials in humans;
  • Obtain FDA approval to treat cancer in people.